ArticleJournal of diabetes investigation2026
Association between continuous glucose monitoring metrics and diabetic retinopathy and albuminuria among Japanese individuals with type 1 diabetes.
Article in Journal of diabetes investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
AIMS/
introductionThis study aimed to clarify the relationship between glucose metrics measured by continuous glucose monitoring (CGM) and diabetic retinopathy (DR) and albuminuria among Japanese individuals with type 1 diabetes mellitus. MATERIALS AND
methodsThe study included 294 individuals with type 1 diabetes (68.7% women) who underwent intermittent scanned CGM between March and April 2023. Multivariable logistic regression analysis was performed to examine the cross-sectional association of each glucose metric (time in range [TIR], time above range [TAR], time below range, glucose management indicator [GMI], and coefficient of variation [CV]) with DR or albuminuria.
resultsThe prevalence of DR and albuminuria was 27.6 and 13.6%, respectively. CGM metrics did not differ between individuals with DR and those without. However, individuals with albuminuria had significantly lower TIR and higher TAR than those without. The presence of DR was significantly associated with higher levels of TAR (odds ratio [OR] = 1.04, P < 0.001), GMI (OR = 2.13, P < 0.001), and HbA1c (OR = 2.07, P < 0.001), and with a lower level of TIR (OR = 0.97, P = 0.005). The presence of albuminuria was significantly associated with higher levels of TAR (OR = 1.05, P = 0.002), GMI (OR = 2.28, P = 0.005), and HbA1c (OR = 2.28, P < 0.001), and with a lower level of TIR (OR = 0.95, P = 0.007).
conclusionDecreased TIR and increased TAR and GMI were independently associated with a higher prevalence of DR and albuminuria in Japanese individuals with type 1 diabetes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.